Radiology Doctors in Offutt Afb, NE Accepting Medicare

4 Radiology doctors found. Showing 1 - 4

Dr. Shane Dennis Dieckman, D.O. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-2448

Dr. Jonathan Muldermans, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-9127

Dr. Marcus Scott Maydew, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-295-7405

Dr. Graham Warden, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 555-867-5309

News Archive

Hedgehog blockade promising in myeloid malignancies

Phase I trial results published in The Lancet Haematology show that the hedgehog signalling pathway antagonist PF-04449913 is tolerable and has activity in patients with haematological cancers.

Findings emphasize importance of counseling HIV patients on smoking cessation

Among HIV patients receiving well-organized care with free access to antiretroviral therapy, those who smoke lose more years of life to smoking than to HIV, according to a Danish study published in Clinical Infectious Diseases and available online. The findings highlight the importance of smoking cessation efforts in the long-term, integrated care of patients infected with HIV.

Pfizer's ORAL Sync Phase 3 study of tofacitinib in moderate-to-severe RA meets primary endpoints

Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.

Patient enrollment completed in pilot study of CyPath labeling solution for early detection of lung cancer

Cancer diagnostics company Biomoda, Inc. today announced it completed patient enrollment and sample collection in a pilot study to determine the clinical sensitivity and specificity of its CyPath labeling solution for the early detection of lung cancer. Top-line data and results will be released when available.

Senate leaders reach agreement on process for considering war supplemental spending bill, Medicaid provision

Senate Majority Leader Harry Reid (D-Nev.) and Minority Leader Mitch McConnell (R-Ky.) on Wednesday reached an agreement on a process for Senate consideration of the war supplemental appropriations bill (HR 2642), including a provision to delay for one year seven new Medicaid regulations proposed by the Bush administration, the AP/Detroit News reports (Taylor, AP/Detroit News, 5/22).

Read more Medical News

› Verified 4 days ago